The Therapeutics Initiative Blog brings you news and information from the world of therapeutics. Bookmark this page to see our frequently refreshed content.
In Therapeutics Letter 136, just published last week, we ask a question some might find provocative: “How do YOU respond to Conflicts of Interest?” In professional edu
Statins and a Patient’s Perspective on Informed Decision-making Occasionally people read our Therapeutics Letters and contact us to share their experiences. These anecdotes are
A study published recently in PLOS One finds that cancer is increased with cumulative exposure to angiotensin-receptor blockers (ARBs). The authors carried out a meta-regression an
In our continued examination of drug safety warnings, researchers with UBC’s Therapeutics Initiative, and others found that warnings about heart risks associated with the ant
In July 2021 we published a Therapeutics Letter on tramadol and advised our readers that “Health Canada has announced that it will add tramadol to Schedule I of the Controlle
The Therapeutics Initiative is excited to extend a warm welcome to the newest member of our team, Dr. Anshula Ambasta, who joins us from Calgary, bringing with her a deep research
A new University of British Columbia study published in the journal Clinical Therapeutics has found that drug companies who sponsor clinical trials in Canada exert influence in som
What do you do as a clinician when you routinely encounter people taking 15 to 20 medications at a time, many of them unnecessary and potentially harmful? That’s the kind of dile
On March 11, 2020 the World Health Organization officially designated Covid19 as a pandemic infection. Two years later, we wish to acknowledge the extraordinary work since late 2
On his show the Human Upgrade, Dave Asprey talks with Dr. John Abramson about his new book Sickening: How Big Pharma Broke American Health Care and How We Can Repair It.” T